Friday, March 28, 2025
spot_img

Allbirds to Participate in the J.P. Morgan Retail Round Up

SAN FRANCISCO, March 20, 2025 (GLOBE NEWSWIRE) — Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make better products in a better way, today announced that Joe Vernachio, CEO, and Annie Mitchell, CFO, will be participating in the following investor conference:

J.P. Morgan Retail Round Up
Thursday, April 3, 2025
New York City

About Allbirds, Inc.

Allbirds is a global modern lifestyle footwear brand, founded in 2015 with a commitment to make better things in a better way. That commitment inspired the company’s first product, the now iconic Wool Runner; and today, inspires a growing assortment of products known for superior comfort. Allbirds designs its products to be materially different by turning away from convention toward nature’s inspiration with materials like Merino wool, tree fiber and sugarcane. For more information, please visit www.allbirds.com.

Investor Relations
[email protected]

Media Contact
[email protected]

Powered by SlickText.com

Hot this week

Intercont (Cayman) Limited Announces Pricing of Its Initial Public Offering

HONG KONG, March 27, 2025 (GLOBE NEWSWIRE)...

Yukon Metals Announces Upsize in Private Placement to C$10M

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR...

CORRECTING and REPLACING: Reed’s Reports Fourth Quarter and Full Year 2024 Results

NORWALK, Conn., March 27, 2025 (GLOBE NEWSWIRE)...

VitalHub Reports Fourth Quarter and Annual 2024 Results

Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1...

Fortuna files Form 40-F, Annual Report

VANCOUVER, British Columbia, March 27, 2025 (GLOBE...

Topics

Yukon Metals Announces Upsize in Private Placement to C$10M

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR...

VitalHub Reports Fourth Quarter and Annual 2024 Results

Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1...

Fortuna files Form 40-F, Annual Report

VANCOUVER, British Columbia, March 27, 2025 (GLOBE...

Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational...
spot_img

Related Articles

Popular Categories

spot_img